Nature Communications

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial

2026-09-07

Full text

DOI https://doi.org/10.1038/s41467-026-77415-1